Small Pharma Inc - ESG Rating & Company Profile powered by AI
The ESG score includes seventeen United Nations Sustainable Development Goals including: 'Zero Hunger', 'Industry, Innovation & Infrastructure' and 'Life on Land'. Check the end of the page for potential risks for Small Pharma Inc based on industry, location and marketcap. This page displays a zero-cost Sustainability analysis covering Small Pharma Inc.
Small Pharma Inc in the Investment Holding Companies industry gained a UN SDG ESG Transparency Score of 4.7; made up of an environmental score of 2.0, social score of 5.3 and governance score of 6.7.
4.7
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Astra Space Inc | 8.7 | High |
| 2 | CK Hutchison Holdings Ltd | 8.2 | High |
| 279 | Pioneer Merger Corp | 4.8 | High |
| 279 | RedBall Acquisition Corp | 4.8 | High |
| 297 | Small Pharma Inc | 4.7 | High |
| 297 | Aumento Capital VIII Corp | 4.7 | High |
| 297 | Apogee Minerals Ltd | 4.7 | High |
| ... | ... | ... | |
| 896 | one | 0.0 | Low |
| 896 | theglobe.com Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Small Pharma Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Small Pharma Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Small Pharma Inc report the average age of the workforce?
Sign up for free to unlockDoes Small Pharma Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Small Pharma Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Small Pharma Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Small Pharma Inc offer flexible work?
Sign up for free to unlockDoes Small Pharma Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Small Pharma Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Small Pharma Inc conduct supply chain audits?
Sign up for free to unlockDoes Small Pharma Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Small Pharma Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Small Pharma Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Small Pharma Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Small Pharma Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Small Pharma Inc disclose water use targets?
Sign up for free to unlockDoes Small Pharma Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Small Pharma Inc have a product recall in the last two years?
Sign up for free to unlockDoes Small Pharma Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Small Pharma Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Small Pharma Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Small Pharma Inc disclose parental leave metrics?
Sign up for free to unlockDoes Small Pharma Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Small Pharma Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Small Pharma Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Small Pharma Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Small Pharma Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Small Pharma Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Small Pharma Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Small Pharma Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Small Pharma Inc disclose its waste policy?
Sign up for free to unlockDoes Small Pharma Inc report according to TCFD requirements?
Sign up for free to unlockDoes Small Pharma Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Small Pharma Inc disclose energy use targets?
Sign up for free to unlockDoes Small Pharma Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Small Pharma Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Small Pharma Inc
These potential risks are based on the size, segment and geographies of the company.
Small Pharma Inc., a biotechnology company, focuses on developing short-acting psychedelics with therapy for the treatment of mental health conditions. Its clinical program is N,N-dimethyltryptamine assisted therapy to treat major depressive disorder. The company's product includes SPL026 Placebo, which is in clinical Phase IIA for the treatment of major depressive disorder. Its preclinical stage programs include SPL028, a prolonged DMT series; SPL029, an oral DMT series; and SPL801 oral formulation of 6-hydroxynorketamin. The company was incorporated in 2015 and is headquartered in London, the United Kingdom.